Iantrek

Raised $42M in a Series C round, announced 20 August 2025.

Total raised: $42M

Latest round Series CCountry United StatesSector Health

Round

$42MSeries C, 20 August 2025

Funds the US commercial launch of AlloFlo Uveo and pipeline expansion.

Amount: $42M
Stage: Series C
Announced: 20 August 2025
Lead: US Venture Partners
Other investors: aMoon Fund, Visionary Ventures, Sectoral Asset Management, Radius Special Situations Fund, Civilization Ventures
Use of funds: Funds the US commercial launch of AlloFlo Uveo and pipeline expansion.
Checked: Announced by the company
Sources: Iantrek raises $42M (date approx) biospace.com
Iantrek raises $42M (date approx) pulse2.com

Company

Surgical glaucoma therapy targeting the uveoscleral outflow pathway

Based in: White Plains, United States
Sector: Health
Website: iantrekmed.com ↗

Questions

How much has Iantrek raised?

Iantrek raised $42M in a Series C round, announced on 20 August 2025.

Who invested in Iantrek?

US Venture Partners led. Investors include US Venture Partners, aMoon Fund, Visionary Ventures, Sectoral Asset Management, Radius Special Situations Fund and Civilization Ventures.